Study of inflammation after heart attack
Part of Heart & circulation clinical trials.
This study tracks inflammation in patients who had a heart attack and received a stent. It aims to understand inflammation levels after the event.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You had a heart attack (acute coronary syndrome) and received a stent (PCI).
- You are being treated in the cardiology department or intensive care unit.
- You have a contact number for follow-up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people after an acute heart attack (AMI) to learn what care is used and what outcomes happen over time. Your information may help doctors optimize how heart attack care is delivered in the future.
This study looks at people who had a heart attack or cardiac arrest to find out which dangerous heart rhythms can happen afterward. The goal is to improve care and prevent future problems.
This study looks at the lymphatic system and heart tissue after a heart attack (STEMI) in people who had prompt catheter treatment. It uses heart MRI to understand healing and may help researchers improve care after a heart attack.
This study looks at whether certain blood markers (related to inflammation and heart damage) can help tell how well your heart is working after a heart attack. By joining, you could help doctors better predict heart function problems and improve care for future patients.
This study uses advanced CT scans to take detailed pictures of your heart and blood vessels after a recent heart attack treated with stent placement. The goal is to better understand heart damage and predict long-term outcomes.
This study examines blood samples from people with different types of coronary artery disease to understand the condition better. It may help doctors learn how to treat heart problems in the future.
Hear when a new Inflammation Biomarkers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.